Literature DB >> 13002681

The use of Rauwolfia serpentina in hypertensive patients.

R W WILKINS, W E JUDSON.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; RAUWOLFIA/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13002681     DOI： 10.1056/NEJM195301082480202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Clinical uses of rauwolfia. I. In arterial hypertension.

Authors:  J GENEST; L ADAMKIEWICZ; R ROBILLARD; G TREMBLAY
Journal:  Can Med Assoc J       Date:  1955-04-01       Impact factor: 8.262

2.  The present status of tranquilzing drugs.

Authors:  L E HOLLISTER
Journal:  Calif Med       Date:  1958-07

3.  [The effect of reserpine on skin and muscle circulation in normal and hypertensive subjects].

Authors:  K D BOCK; H MULLER
Journal:  Klin Wochenschr       Date:  1956-03-15

4.  Hyperchlorhydria induced by intravenous reserpine; response to various therapeutic agents.

Authors:  E M SCHNEIDER; M L CLARK
Journal:  Am J Dig Dis       Date:  1956-01

5.  Drug Treatment of Hypertension.

Authors: 
Journal:  Br Med J       Date:  1954-06-19

6.  Rustom Jal Vakil: his contributions to cardiology.

Authors:  Sumit Isharwal; Shubham Gupta
Journal:  Tex Heart Inst J       Date:  2006

Review 7.  Blood pressure-lowering efficacy of reserpine for primary hypertension.

Authors:  Sandy D Shamon; Marco I Perez
Journal:  Cochrane Database Syst Rev       Date:  2016-12-21

8.  ROBERT WALLACE WILKINS, MD: 1906 - 2003.

Authors: 
Journal:  Trans Am Clin Climatol Assoc       Date:  2022

Review 9.  Rauwolfia in the Treatment of Hypertension.

Authors:  Douglas Lobay
Journal:  Integr Med (Encinitas)       Date:  2015-06

10.  Vesicular monoamine transporter 2 mediates fear behavior in mice.

Authors:  Rachel C Branco; James P Burkett; Carlie A Black; Emily Winokur; William Ellsworth; Rohan K Dhamsania; Kelly M Lohr; Jason P Schroeder; David Weinshenker; Tanja Jovanovic; Gary W Miller
Journal:  Genes Brain Behav       Date:  2020-01-14       Impact factor: 3.449
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.